1. Home
  2. PGY vs ANIP Comparison

PGY vs ANIP Comparison

Compare PGY & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$18.43

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo ANI Pharmaceuticals Inc.

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$71.69

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGY
ANIP
Founded
2016
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
2021
1999

Fundamental Metrics

Financial Performance
Metric
PGY
ANIP
Price
$18.43
$71.69
Analyst Decision
Strong Buy
Buy
Analyst Count
11
9
Target Price
$28.91
★ $105.78
AVG Volume (30 Days)
★ 2.3M
327.9K
Earning Date
11-09-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
116.43
★ 419.23
EPS
0.77
★ 2.32
Revenue
★ $1,301,360,000.00
$206,547,000.00
Revenue This Year
$12.53
$25.00
Revenue Next Year
$15.85
$11.39
P/E Ratio
★ $23.91
$31.33
Revenue Growth
★ 26.07
2.47
52 Week Low
$10.40
$69.58
52 Week High
$31.54
$96.99

Technical Indicators

Market Signals
Indicator
PGY
ANIP
Relative Strength Index (RSI) 42.15 41.43
Support Level $16.34 $69.87
Resistance Level $19.14 $83.03
Average True Range (ATR) 0.99 2.43
MACD -0.21 -0.15
Stochastic Oscillator 31.57 8.92

Price Performance

Historical Comparison
PGY
ANIP

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: